KOR

e-Article

Preclinical Development of EDIT301, an Autologous Cell Therapy Comprising AsCas12a-RNP Modified Mobilized Peripheral Blood-CD34 (+) Cells for the Potential Treatment of Transfusion Dependent Beta Thalassemia
Document Type
Journal
Source
BLOOD; NOV 23 2021, 138 p1858-p+, 3p. Supplement: 1
Subject
Language
English
ISSN
15280020